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Abstract
The contribution of interleukin-3 (IL-3), a hematopoietic growth factor and
immunoregulatory cytokine, to resistance to blood-stage malaria was investigated by
infecting IL-3-deficient (knockout [KO]) mice with Plasmodium berghei NK65. The
results show that endogenous IL-3 significantly alters the susceptibility of BALB/c mice
to P. berghei NK65 infection as reflected by measures of survival, anemia, parasitemia,
and splenomegaly. Male IL-3 KO mice, but not female mice, were more resistant to
infection than wild-type (WT) mice, as evidenced by lower peak parasitemia and
prolonged survival. Both male and female IL-3 KO mice had increased splenomegaly and
were more anemic than corresponding WT mice. Anemia was compensated for by an
increase in bone marrow and splenic erythropoiesis in male IL-3 KO mice, as evidenced
by higher levels of erythroid progenitors. P. berghei NK65 infection was also shown to
induce IL-3-dependent changes in plasma cytokine levels: plasma levels of gamma
interferon (IFN-γ) and chemokine (C-X-C motif) ligand 9 (CXCL9 or monokine induced
by IFN-γ [MIG]) were found to be significantly reduced in male IL-3 KO mice during
early stages of infection. In contrast, granulocyte colony-stimulating factor (G-CSF)
levels were significantly higher, and the percentage of peripheral blood neutrophils
lower, in P. berghei NK65-infected male IL-3 KO mice than in WT counterparts. P.
berghei NK65 infection induced degranulation of splenic mast cells in both male IL-3
KO and WT mice; however, there was no difference in mast cell numbers between
genotypes. Overall, our results indicate that IL-3 plays a critical role in suppressing
protective immunity to P. berghei NK65 infection and that it is involved in inhibiting the
development of splenomegaly, anemia, and erythropoiesis. IL-3 also influences IFN-γ,
viii

CXCL9, and G-CSF production in response to infection. The abnormal responses seen in
infected IL-3 KO mice may be due to the lack of IL-3 during development, to the lack of
IL-3 in the infected mature mice, or to both.
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Introduction
Malaria:
Malaria is a tropical infectious disease caused by protozoan parasites of the genus
Plasmodium and spread by Anopheles mosquitoes. The World Health Organization
estimates that malaria infected 207 million people and killed 627,000 in 2012 (WHO,
2013), ranking this disease among the greatest threats to global public health.
Four species of Plasmodium have infected humans throughout history: P.
falciparum, P. vivax, P. ovale, and P. malariae; P. falciparum is the most virulent species
and accounts for most malaria-related mortality (Neghina et al., 2010). In recent years the
primate malaria, P. knowlesi, has also emerged as a zoonotic human pathogen (Müller
and Schlagenhauf, 2014). Malaria – classically characterized by periodic chills, rigors,
and high fevers followed by profuse sweating – has been described in the Chinese
literature as far back as 2700 B.C., and has had a major impact on human history ever
since (Neghina et al., 2010).
Although it was originally observed that malaria was associated with swampy
areas and frequently disappeared when the swamps were filled, this was commonly
attributed, not to the mosquitoes who bred in the swamps, but to “bad air,” giving rise to
the Italian name for the disease - mal aria (Neghina et al., 2010). The true cause of
malaria was not discovered until 1880, when the French military surgeon Alphonse
Laveran described parasites found in the blood of malaria patients. Shortly thereafter,
British doctor Ronald Ross made the Nobel Prize-winning discovery that malaria was
transmitted by mosquitoes (Neghina et al., 2010).
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The first effective treatment for malaria was quinine, which was isolated from the
bark of the Peruvian Chinchona tree by French chemists Joseph Pelletier and Jean
Bienaime Caventou in 1820 (Butler et al., 2010). During WWII, American scientists
developed a synthetic antimalarial drug called chloroquine, which quickly became the
standard of treatment for malaria (Butler et al., 2010). By the 1970s, however, resistance
to chloroquine and its derivatives was becoming widespread (Butler et al., 2010). The
current treatment of choice for malaria is artemisinin, which is isolated from qing hao, an
herb long used to treat intermittent fever in traditional Chinese medicine (Butler et al.,
2010). The World Health Organization recommends combining artemisinin with other
drug therapies in order to prevent the development of resistance. However, the first
strains of artemisinin-resistant strains of Plasmodium have already been identified at the
Thailand-Cambodia border in a series of studies conducted between 2001 and 2009
(WHO 2011).
The intensive Roll Back Malaria Partnership launched in 1998 has reduced
malaria cases by 50% in 43 countries over the past decade; unfortunately, the
development of artemisinin-resistant strains puts these gains at risk, renewing interest in
the development of a malaria vaccine (WHO, 2011). In spite of the fact that studies
conducted in the 1970s indicated that humans could be immunized against malaria by the
bites of large numbers of irradiated, infected mosquitoes (Clyde et al., 1975), attempts to
create a practical malaria vaccine have been largely unsuccessful. The most promising
vaccine candidate to date is the sporozoites subunit vaccine RTS,S, which has shown 30
– 50% efficacy in clinical trials; however, protection is relatively short-lived (Arama et
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al., 2014). The development of an effective vaccine depends on obtaining a detailed
understanding of the immune response to malaria infection.
Malaria Life Cycle:
Malaria infection begins when an infected female Anopheles mosquito takes a
blood meal from a human and injects salivary fluids containing motile, spindle-shaped
sporozoites into the wound (Despommier et al., 2006). The sporozoites migrate to the
liver, where they invade liver cells and undergo asexual division until the host cells burst,
releasing thousands of merozoites into the bloodstream (Despommier et al., 2006). The
merozoites invade red blood cells (RBCs), feeding on hemoglobin and growing into the
larger, ring-shaped trophozoites. The parasite then undergoes asexual division to become
a schizont: a large, multinucleate cell containing more merozoites. The RBC eventually
ruptures, releasing the merozoites into the bloodstream to infect more RBCs and continue
the cycle (Despommier et al., 2006). Some of the merozoites differentiate into
gametocytes, the parasite’s sexual form. Gametocytes can only complete their life cycle
within the gut of an Anopheles mosquito. Once ingested as part of the mosquito’s blood
meal, the “male” microgametocytes fertilize the “female” macrogametocytes
(Despommier et al., 2006). The resulting zygotes develop into oocysts, each containing
over a thousand sporozoites. Once the sporozoites emerge from the oocyst, they migrate
to the mosquito’s salivary glands, ready to infect the mosquito’s next blood meal
(Despommier et al., 2006) (Figure 1).
Clinical Aspects and Pathology of Malaria:
Several species of Plasmodium infect humans, but P. falciparum causes the most
severe disease and nearly all mortality (Despommier et al., 2006). The pathogenic
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Figure 1. Malaria life cycle in both the human host and the mosquito vector (adapted
from Thayer, 2005.)
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consequences of malaria infection are caused by the erythrocytic cycle (also called the
“blood-stage”), during which circulating merozoites repeatedly infect and lyse RBCs.
The lysed cells release pyrogens – inflammatory substances which cause the periodic
chills, fever, and sweating which characterize the acute phase of malaria infection
(Despommier et al., 2006). About 10% of P. falciparum infections develop serious
complications, including severe anemia, respiratory distress, and cerebral malaria. The
over-all mortality rate of P. falciparum is 1%, but severe malaria involving one of these
complications has a mortality rate of 10 – 50% (Wiser, 2011).
The pathology of anemia involves a number of factors: the severity of anemia
correlates with the degree of parasitemia and is caused by the destruction of RBCs, bone
marrow suppression, and increased osmotic fragility of uninfected RBCs (Lamikanra et
al., 2007). Respiratory distress syndrome has only relatively recently been recognized as
an important malaria complication, and is actually a better predictor of mortality than
severe anemia or cerebral malaria (Wiser, 2011). As RBCs are destroyed, the uptake of
oxygen and release of carbon dioxide becomes impaired. Excess carbon dioxide raises
the acidity of the blood, a condition known as metabolic acidosis. The disturbed pH
balance causes fluid to build up in the lungs, leading to difficulty breathing and eventual
respiratory failure (Taylor et al., 2012).
Cerebral malaria, long considered the most severe complication of malaria
infection, is caused by a complex interplay of parasite virulence, host susceptibility, and
immunopathology that is still not completely understood. Cerebral malaria is
characterized by mechanical occlusion and inflammation of the cerebral microvasculature
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and breakdown of the blood-brain barrier (Shikani et al., 2012). Briefly, parasitized
RBCs (pRBCs) adhere to the inner walls of capillaries in the brain, causing local overproduction of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-α)
(Wiser, 2011). The pRBCs also adhere to one another, forming large clumps called
rosettes which can physically block capillaries (Wiser, 2011). Although both of these
phenomena have been associated with cerebral malaria, the relative contribution of each,
and the exact mechanisms by which they lead to clinical disease, have not yet been fully
explicated (Wiser, 2011). The symptoms of cerebral malaria include severe headache and
fever progressing to impaired consciousness and other neurological symptoms such as
convulsions, vomiting, and respiratory distress. If not treated, cerebral malaria can
quickly progress to coma and death (Wiser, 2011).
Malaria Immunology and Immunopathology:
The initial response to malaria infection is a cellular response characterized by the
release of pro-inflammatory cytokines such as IFN-γ and TNF-α, which activate
macrophages to more efficiently phagocytize parasites and pRBCs (Angulo and Fresno,
2002; Langhorne et al., 2008). Although IFN-γ and TNF-α have both been shown to be
essential to parasite clearance, over-production of these cytokines can cause pathology,
including cerebral malaria (Angulo and Fresno, 2002; Langhorne et al., 2008). At 7 - 10
days postinfection (p.i.), the anti-inflammatory Th2 cytokine IL-4 begins to downregulate cellular immunity, including the production of IFN-γ, and stimulate humoral
immunity and antibody production (Helmby et al., 1998). As Plasmodium parasites are
both intra- and extra-cellular at different stages of their life cycle, both cellular and
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humoral immunity are believed to be essential to parasite clearance (Angulo and Fresno,
2002; Langhorne et al., 2008).
Studies indicate that the most effective anti-malaria antibodies are the opsonizing
antibodies IgG1 and IgG3, which enhance the phagocytosis of parasites and infected
RBCs (Perlmann and Troye-Blomberg, 2000; Langhorne et al.. 2008). In contrast, IgE
antibodies have been shown to exacerbate pathology by forming immune complexes
which cross-link receptors on monocytes and endothelial cells, stimulating them to
release TNF-α (Perlmann and Troye-Blomberg, 2000). Overproduction of TNF-α in the
blood vessels of the brain can lead to inflammation and cerebral malaria (Perlmann and
Troye-Blomberg, 2000).
Unlike many diseases, recovery from malaria infection does not result in classical
“sterile” immunity, in which previously encountered pathogens are quickly eliminated
before causing symptoms. This is due in part to the fact that Plasmodium parasites
change their surface antigens to avoid recognition by the adaptive immune system
(Wiser, 2011). However, people living in endemic areas do develop a degree of resistance
to the clinical manifestations of malaria infection, a phenomenon known as premunition
(Angulo and Fresno, 2002; Langhorne et al., 2008). This is why the majority of patients
who die of malaria are young children – they have not yet experienced enough exposures
to develop premunition (Langhorne et al., 2008).
Mouse Models of Malaria:
Animal studies, primarily in rodents, have played a key role in elucidating the
mechanisms by which Plasmodium infection causes disease as well as the host immune
response and immunopathology. Four species of Plasmodium naturally infect African
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rodents: P. vinckei, P. berghei, P. chabaudi, and P. yoelii (Stephens et al., 2012); the last
three of these are commonly used to infect mice in the laboratory (Zuzarte-Luis et al.,
2014). Mice may be infected via mosquito bite in order to study both the exoerythrocytic
and the erythrocytic stages of Plasmodium infection; alternately, mice may be infected
via intravenous (i.v.) or intraperitoneal (i.p.) injection in order to study the erythrocytic
cycle alone (Zuzarte-Luis et al., 2014).
The course and outcome of infection differ depending on both the Plasmodium
species and the strain of mouse used. For example, P. berghei ANKA causes cerebral
malaria in C57BL/6 but not BALB/c mice, although it is fatal in both species (ZuzarteLuis et al., 2014). P. chabaudi is non-lethal in most mouse strains, while P. yoelii may be
lethal or non-lethal depending on the parasite strain (Stephens et al., 2012; Zuzarte-Luis
et al., 2014).
P. berghei NK65 does not cause cerebral malaria but is fatal in BALB/c mice,
typically within 2 weeks postinfection (Lacerda-Queiroz et al., 2011). Mice infected with
P.berghei NK65 develop many of the same symptoms as humans, including weight loss,
severe anemia, splenomegaly, and immune-mediated liver injury (which is caused by
blood-stage malaria infection as distinct from the destruction of hepatocytes during the
exoerythrocytic stage) (Zuzarte-Luis et al., 2014). Although P. berghei NK65 infection
does not cause the neurological symptoms of classical experimental cerebral malaria
(ataxia, paralysis, convulsions, and coma followed by death), P. berghei NK65-infected
BALB/c mice do show increased cerebral vascular permeability and levels of leukocyte
rolling and adhesion comparable to that seen in P. berghei ANKA infection (Lacerda-
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Queiroz et al., 2011). Infected mice typically develop a rough hair coat and lethargy,
eventually progressing to complete prostration shortly before death. (Figure 2).
Interleukin-3:
Interleukin-3 (IL-3) is a 28-kDa glycoprotein of 133 amino acids in humans and
140 amino acids in mice (Schrader, 1998). It was first discovered as a factor produced by
activated T cells and the murine myelocytic leukemia cell line WEHI-3B, which induced
the expression of the T cell associated, progesterone-reducing enzyme 20αhydroxysteroid dehydrogenase in nude mouse splenocytes in vitro (Ihle, 1992; Weinstein,
1977). It was shown that this factor induced the in vitro proliferation of cells of the
myeloid lineage in cell culture: mast cells, neutrophils, macrophages, eosinophils,
megakaryocytes, and erythroid progenitors (Schrader, 1998). IL-3 has a 4-helix-bundle
structure which it shares with a number of colony stimulating factors, growth factors, and
cytokines (Schrader, 1998). In particular, IL-3 shares a number of structural and
functional similarities with interleukin-5 (IL-5) and granulocyte macrophage colony
stimulating factor (GM-CSF), with which it forms a cytokine family (Broughton et al.,
2012). IL-3 exerts its biological effects through a receptor that is composed of a ligandspecific α (IL3RA) subunit and a signal transducing β subunit (IL3RB) common to
IL- 3/IL-5/GM-CSF. Unlike in humans, the mouse IL-3 receptor has two distinct β
subunits, one that functions only in IL-3-mediated cell signaling (βIL3) and a second that
is shared with IL-5 and GM-CSF (IL3RB) (Itoh et al., 1990).
IL-3 is expressed mainly by activated T lymphocytes and mast cells, however,
eosinophils, keratinocytes, NK cells and endothelial cells have been reported to secrete
this cytokine under some circumstances (Broughton et al., 2012). IL-3 is not produced
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Figure 2. Image of a healthy (A) and a P. berghei NK65-infected (B) BALB/c mouse.

13

constitutively and is dispensable for steady-state hematopoiesis. In vivo administration of
IL-3 can enhance hematopoiesis in mice and experimental primates (Marone et al.,
2000). In addition to supporting the survival and proliferation of myeloid progenitor cells,
IL-3 also enhances the functions of a variety of cell types. In in vitro studies, IL-3
enhances macrophage antigen presentation (Frendl and Beller, 1990), cytotoxicity, and
adherence (Mach et al., 1998), promotes mast cell growth, differentiation, and mediator
release (Hu et al., 2007, Gurish and Boyce, 2002), and promotes basophil development
and enhances the release of histamine, IL-4, and IL-6 (Voehringer, 2012, Karasuyama et
al., 2011, Lantz et al., 2008). Mast cell precursors are particularly sensitive to the growth
promoting properties of IL-3. For example, when mouse hematopoietic cells (e.g. bone
marrow cells) are maintained in vitro with IL-3 as the only exogenous cytokine, an
essentially homogeneous population of mast cells develop within approximately 3-4
weeks. IL-3 also enhances inflammation by up-regulating the expression of adhesion
molecules on endothelial cells (Khew-Goodall et al., 2006) and promoting the adhesion
of basophils and eosinophils to the endothelium in preparation for tissue infiltration (Lim
et al., 2006). Finally, IL-3 has been shown to promote the secretion of the important
inflammatory cytokine TNF-α by antigen-activated monocytes (Cannistra et al., 1988),
and modulates the development of regulatory T (Treg) cells (Srivastava et al., 2011). As
several of the functions of IL-3 enhance the inflammatory immune response, IL-3 may
influence the outcome of malaria infection by enhancing the inflammatory immune
response. This could be beneficial or detrimental depending on the strength and timing
of the inflammatory response (Angulo and Fresno, 2002; Langhorne et al., 2008).
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In order to obtain a better understanding of the role of endogenous IL-3 in vivo,
IL-3-deficient (“knockout” or KO) mice were generated by homologous recombination in
embryonic stem cells in (Mach et al., 1998). As expected, IL-3 KO mice showed no
deficiency in steady-state hematopoiesis and had normal numbers of basophils and tissue
mast cells (Mach et al., 1998; Lantz et al., 1998). These mice did, however, have an
attenuated delayed-type contact hypersensitivity response to epicutaneously applied
haptens (Mach et al., 1998). In addition, IL-3 KO mice infected with the intestinal
nematode Strongyloides venezuelensis have an attenuated immune response that results in
delayed worm expulsion and prolonged shedding of parasite eggs in IL-3 KO mice
(Lantz et al., 1998). S. venezuelensis infection in mice is normally resolved with a T celldependent immune response that includes extensive mast cell hyperplasia in the intestinal
mucosa as well as increased numbers of basophils in the bone marrow (Lantz et al.,
1998). S. venezuelensis-infected IL-3 KO mice, however, showed no increase in bone
marrow basophils over baseline and substantially decreased mast cell hyperplasia (Lantz
et al., 1998). Similar experiments using IL-3 KO mice infected with the intestinal
nematode Nippostrongylus brasiliensis showed that IL-3 was necessary for increased
basophil numbers in blood and bone marrow as well as enhancing the production of IL-4
by IgE-stimulated basophils (Lantz et al., 2008). Over-all, these results support the
hypothesis that IL-3 acts as a link between the hematopoietic and immune systems, and is
particularly important as a promoter of the development, survival, and functions of mast
cells and basophils (Marone et al., 2000).
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Interleukin-3 and Malaria:
Since the initial description of IL-3 in the early 1980s, a potential role for IL-3 in
the pathophysiology of malaria has rarely been reported. An increase in IL-3 serum levels
was detected in P. chabaudi-infected mice preceding and around the time of peak
parasitemia (Helmby et al., 1998). This increase was accompanied by an increase in nonB non-T cells (later recognized as basophils) secreting IL-4 and IL-6 in response to
stimulation with IL-3, suggesting that IL-3 could play a role in the switch from Th1 to
Th2 immunity (Helmby et al., 1998, Poorafshar et al., 2000). Likewise, IL-3-dependent
mast cells and their products have also been shown to influence the outcome of malaria
infection. Increases in splenic mast cells have been reported in response to malaria
infection, and mast cell-derived TNF-α appears to exert a protective effect on immunity
to malaria (Furuta et al., 2006). Infection-activated mast cells also release Flt3 ligand,
which is necessary for the expansion of dendritic cells in response to malaria infections
(Guermonprez et al., 2013). Grau et al. have shown that treatment of P. berghei NK65infected CBA mice with anti-IL-3 and anti-GM-CSF antibodies prevents development of
cerebral malaria and prolongs survival, possibly by preventing increases in TNF-α (Grau
et al., 1988). It was also demonstrated that IL-3 may increase adhesion of parasitized
erythrocytes to endothelial cells and promotes pRBC rosetting, a phenomenon associated
with the pathophysiology of severe malaria (Carlson et al., 1990). More recently, a
genetic survey of Ghanian children found that certain single nucleotide polymorphisms
(SNPs) in the IL-3 gene exert a protective effect against recurrent malaria attacks (Meyer
et al., 2011). However, it is not yet known whether these SNPs result in gain, loss, or
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change of IL-3 function, so it cannot be ascertained whether IL-3 exerts a protective or
detrimental effect on malaria infection (Meyer et al., 2011).
General Research Strategy:
A limited number of studies have reported that IL-3 may be involved in the
susceptibility of mice to infection with Plasmodium. However, the precise role of IL-3 in
malaria infection has yet to be addressed. For this project, BALB/c IL-3 KO mice and
their wild type (WT) counterparts were used to test two major but related hypotheses: 1)
that endogenous IL-3 significantly alters the susceptibility of BALB/c mice to
Plasmodium berghei NK65 infection as reflected by measures of survival, anemia,
parasitemia, and splenomegaly, and 2) that Plasmodium berghei NK65 infection induces
IL-3-dependent changes in the levels of plasma cytokines and tissue mast cells.
Aim 1. Assess the extent to which IL-3 influences the course and outcome of disease
in Plasmodium berghei NK65-infected BALB/c mice. BALB/c IL-3 KO mice and WT
mice infected with P. berghei NK65 were used to test the hypothesis that endogenous IL3 influences the course and outcome of the infection as monitored by survival, anemia,
parasitemia, splenomegaly, and mature and immature RBC levels. The kinetics of IL-3
production during the course of the infection were evaluated by assaying IL-3 secretion
from antigen-stimulated splenocyte cultures using cells obtained from P. berghei NK65infected WT mice.
Aim 2. Assess the extent to which IL-3 influences cytokine levels and tissue mast
cells in Plasmodium berghei NK65-infected BALB/c mice. BALB/c IL-3 KO mice and
WT mice infected with P. berghei NK65 were used to test the hypothesis that
endogenous IL-3 alters the levels of plasma cytokines as measured by a 32-analyte
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multiplex cytokine immunoassay, and that the absence of IL-3 during infection results in
reduced numbers of detectable splenic mast cells.

Materials and Methods

Mice. The production of BALB/c IL-3-deficient mice and many of the phenotypic
characteristics of these mice have been described in detail (Mach et al., 1998). Male and
female BALB/c mice (purchased from The Jackson Laboratory, Bar Harbor, ME) were
used as wild-type (WT) controls. For these studies, mice were 8 to 12 weeks of age at the
beginning of the experiments. In individual experiments, mice of the same approximate
age (within 1 week) and size were used. Mice were housed in a positive, individually
ventilated caging system (Allentown Inc., Allentown, NJ) in the Department of Biology’s
animal facility under a 14-h/10-h light/dark cycle and were maintained and used in
accordance with James Madison University’s Institutional Animal Care guidelines.
Plasmodium berghei NK65 infection and evaluation of disease. Cryopreserved P.
berghei NK65A (ATCC 50175) was passaged once through WT BALB/c mice
before being used to infect experimental animals. Mice were infected with blood stages
of P. berghei NK65 by injecting 105 pRBC i.p. Blood collected from the retro-orbital
sinus into heparinized tubes was used to determine hematocrit, and the plasma was stored
frozen at -80°C. Parasitemia was monitored by examination of Giemsa-stained blood
films using light microscopy. Spleens from uninfected and infected mice were harvested
at the indicated days postinfection with P. berghei NK65. The splenic index for each
individual mouse was calculated based on the spleen weight (mg)/body weight (g) x
1000. Infected mice used for mortality studies were monitored daily beginning at day 1
p.i.

19

Quantification of blood neutrophils and splenic mast cells. The proportion of
neutrophils in blood was determined by counting 200 total leukocytes present in MayGrünwald Giemsa-stained blood films. Spleen sections were fixed in 10% buffered
formalin, and 5 µm paraffin sectioning and staining was performed by Histo-Scientific
Research Laboratories (Mt. Jackson, VA). Pinacyanol erythrosinate stain was used to
identify splenic mast cells, and the numbers were quantified according to area (mm2)
using computer-generated image analysis (Nikon NIS Elements software, version
3.22.11).
Hematoxylin and eosin staining. Additional slides were stained with hematoxylin and
eosin (H&E) for general histological evaluation. Spleen sections were fixed in 10%
buffered formalin, and 5 µm paraffin sectioning and staining was performed by HistoScientific Research Laboratories (Mt. Jackson, VA).
Erythroid progenitor assays. Single-cell suspensions were prepared from bone marrow
and spleen in Iscove’s modified Dulbecco’s medium (Lonza, Walkersville, MD)
containing 5% fetal bovine serum (FBS), and erythrocytes were lysed with RBC lysis
solution (Miltenyi Biotec Inc., Auburn, CA). Cell suspensions were pooled according to
genotype, and colony assays were performed by plating cells in MethoCult (StemCell
Technologies, Vancouver, BC, Canada) containing appropriate cytokines according to the
manufacturer’s instructions. For CFU-erythroids (CFU-Es), cells were plated in M3334
MethoCult already containing erythropoietin; for mature burst-forming-unit-erythroids
(BFU-Es), cells were plated in M3436 MethoCult, which contains a proprietary
combination of cytokines, including erythropoietin. Bone marrow cells were plated at 3 x
105/35-mm dish and spleen cells were plated at 2 x 105/35-mm dish, and the dishes were

20

incubated in triplicate at 37°C and 5% CO2. CFU-E and BFU-E colonies were
enumerated using an inverted microscope on days 2 and 10 of culture, respectively.
Preparation of P. berghei NK65 antigens. Plasmodium berghei NK65 crude antigen,
used to stimulate splenocytes in vitro, was prepared as described previously (Amante,
2001). Briefly, P. berghei NK65 pRBCs collected from 10 WT mice at day 8 p.i. were
centrifuged twice in PBS, and cells were lysed twice by adding distilled water and
centrifuging at 290 x g, 4°C, for 10 min. The suspension was then centrifuged twice in
PBS at 16,000 x g, 4°C, and the pellet was subjected to three cycles of freezing at -80°C
and thawing at 37°C in 10 ml PBS. The lysate was further disrupted by passing through a
1-ml syringe with a 26-gauge needle seven times. RBCs collected from uninfected WT
mice were subjected to the same procedure in order to obtain control antigen. All lysates
were quantified using the Micro-BCA (bicinchoninic acid) protein assay kit (Thermo
Scientific, Rockford, IL) and frozen at -80°C until use.
IL-3 production by cultured splenocytes. Spleens were removed aseptically at the
indicated times, and single-cell suspensions were prepared by homogenizing through a 70
µm cell strainer. Following hematolysis with RBC lysis solution, the cell suspensions
were washed and suspended in RPMI 1640 medium (Lonza BioWhittaker, Walkersville,
MD) supplemented with 10% heat-inactivated FBS along with 100 U penicillin and 100
µg of streptomycin per ml. The cells were cultured at 5 x 106 cells/well in 1 ml of
complete RPMI 1640 medium in 24-well plates for 48 h at 37°C and 5% CO2. Cells were
cultured either in the presence of P. berghei NK65 crude antigen (100 µg/ml), in medium
alone, or with control antigen prepared from uninfected RBCs. Concanavalin A (2 µg/ml)
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was used as a positive control. Supernatants were frozen at -80°C until assayed for IL-3
by enzyme-linked immunosorbent assay (ELISA) (eBioscience, San Diego, CA).
Quantification of cytokines. Plasma cytokine/chemokine levels were assayed in
duplicate using a 32-analyte multiplex cytokine immunoassay based on xMAP
technology (no. MCYTMAG-70K-PX32; Millipore Milliplex, Billerica, MA) on a
MAGPIX multiplexing instrument (Luminex Technologies, Austin, TX). Mouse
cytokines/chemokines assayed included eotaxin, G-CSF, GM-CSF, gamma interferon
(IFN-γ), IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12 (p40), IL-12
(p70), IL-13, IL-15, IL-17, IP-10, keratinocyte-derived chemokine (KC), leukemia
inhibitory factor (LIF), lipopolysaccharide-induced CXC chemokine (LIX), monocyte
chemoattractant protein 1 (MCP-1), macrophage colony stimulating factor (M-CSF),
monokine induced by IFN-γ (MIG or CXCL9), macrophage inflammatory protein 1α
(MIP-1α), MIP-1β, MIP-2, RANTES, TNF-α, and vascular endothelial growth factor
(VEGF).
Statistical analysis. Data are presented as the means ± standard deviations from the
means (SD). To assess the statistical significance between mean values influenced by two
variables, a two-way or repeated analysis of variance (ANOVA) followed by Bonferroni
post-test was performed; an unpaired t-test was used to compare one variable between
two groups. Survival data were analyzed using the log-rank (Mantel-Cox) test. A
significance level of 0.05 was used for all comparisons. All statistical analyses were
performed using GraphPad Prism, version 5.02 (GraphPad Software, La Jolla, CA).

Results
Male, but not female, P. berghei NK65-infected IL-3 KO mice have prolonged
survival and reduced parasitemia compared to WT counterparts.
P. berghei NK65 is uniformly fatal in BALB/c mice, often within 10 days p.i. In
order to test the effect of IL-3 deficiency on mortality, 7 WT and KO mice of each sex
were infected with 105 P. berghei NK65-infected RBCs via i.p. injection. While all 7
male WT mice died 8 – 13 days p.i., male IL-3 KO mice survived significantly longer,
with 4 dying 14 – 19 days p.i. and the remaining 3 surviving 3 weeks or longer before
succumbing to death (Figure 3A). In contrast, there was no significant difference
between female WT and KO mortality, with the majority of mice in both genotypes
surviving past 3 weeks (Figure 3B). Correlating with their prolonged survival, male IL-3
KO mice also have lower % parasitemia compared to WT mice, with the difference
becoming significant by days 8 - 10 p.i., shortly before the death of the WT mice (Figure
3C.) In contrast, no significant difference in parasitemia was detected in female WT and
KO mice at day 10 p.i. (WT: 15.9 ± 4.2; KO: 17.6 ± 2.9; n = 7/group; p = 0.40).
Both male and female P. berghei NK65-infected IL-3 KO mice have increased
splenomegaly compared to WT counterparts, but male mice had no increase in
splenic mast cells.
The spleen plays a major role in the host immune response to malaria infection,
and spleen enlargement (splenomegaly) is a major symptom of malaria infection in both
humans and rodents. The effect of IL-3 deficiency on the development of splenomegaly
in P. berghei NK65-infected mice was determined by measuring the splenic indices of
both male and female IL-3 KO and WT mice at day 8 p.i. (males) and day 10 p.i.
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Figure 3. Survival rate of P. berghei NK65-infected male (A) and female (B) WT and
IL-3 KO mice (n = 7 mice/group). A statistically significant difference in survival
between infected male WT and IL-3 KO mice was observed (P = 0.0002). (C) Time
course of parasitemia in P. berghei NK65-infected male WT and IL-3 KO. ***, P <
0.001 versus corresponding values for mice of the other genotype. Data are presented as
means ± SD and are representative of two (C) or three (A and B) independent
experiments.
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(females). As shown in Figure 4, there is no significant difference between the splenic
indices of uninfected male or female mice of either genotype. Infected males and females
of both genotypes developed significant splenomegaly compared to uninfected mice, with
infected IL-3 KO mice having significantly higher splenic indices than infected WT mice
(Figure 4).
Mast cells have been shown to influence the immunopathology of malaria
infection in rodents (Furuta et al., 2006; Guermonprez et al., 2013). Since IL-3 supports
the proliferation of mast cells, mast cells were counted in pinacyanol erythrosinate
stained spleen sections taken from uninfected and P. berghei NK65-infected male WT
and KO mice (Figure 5). WT and KO mice had similar numbers of mast cells/mm2 of
tissue both before and after infection; however, both WT and KO had a significant
decrease in splenic mast cell counts after infection (Table 1.)
Hematoxylin-eosin (H&E) staining was also performed on spleen sections in
order to compare the relative areas of red and white pulp between uninfected and P.
berghei NK65-infected male WT and KO mice (Figure 6). Spleens of uninfected WT and
KO mice were similar, with well-defined areas of white pulp surrounded by a visible
marginal zone separating them from the red pulp. After infection, however, the spleens of
both WT and KO mice showed a dramatic loss of definition between the red and white
pulp and shrinkage of the marginal zone (Figure 6).
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Figure 4. Splenic index in uninfected and P. berghei NK65-infected male and female WT
and IL-3 KO mice. Spleen weights of infected mice were determined on day 8 (male) and
day 10 (female) p.i. The splenic index was determined as the ratio of spleen weight to
body weight. Data from uninfected male and female mice of each genotype were not
significantly different and were pooled. All data are presented as means ± SD from 4 to 6
mice per group analyzed individually. ***, P < 0.001 versus corresponding values for
uninfected mice or (as indicated by the square brackets) versus corresponding values for
mice of the other genotype. The data are representative of three independent experiments.
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Figure 5. Granulated mast cells shown in a 5µm spleen section. Spleen sections were
paraffin-embedded, formalin-fixed, stained with pinacyanol erythrosinate, and viewed at
1000X magnification.
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Table 1. Mast cells/mm2 counted in 5 µm spleen sections taken from uninfected and P.
berghei NK65-infected (day 8 p.i.) male WT and KO mice. Spleen sections were
paraffin-embedded, formalin-fixed, and stained with pinacyanol erythrosinate.

Mast cells/mm2

a

WT

KO

Uninfected

14.1 ± 2.7

16.0 ± 4.1

Infected

2.6 ± 2.0a

1.9 ±0.6a

Statistically significant difference compared to uninfected mice of the same genotype
(P < 0.01).
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Figure 6. H&E-stained spleen sections from (A) uninfected, (B) P. berghei NK65infected male WT, and (C) P. berghei-NK65 infected male KO mice. Sections viewed at
100X magnification.
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P. berghei NK65-infected IL-3 KO mice have increased anemia and erythropoiesis
compared to WT counterparts
A major cause of both morbidity and mortality in Plasmodium-infected humans
and rodents is anemia due to the destruction of infected and uninfected RBCs as well as
infection-induced suppression of erythropoiesis. In order to determine the effect of IL-3
on P. berghei NK65-induced anemia, hematocrits were measured in male and female
mice of both genotypes at day 8 p.i. (males and females) and at day 10 p.i. (females).
Male and female mice of both genotypes had decreased hematocrits compared to
uninfected counterparts, but P. berghei NK65-infected IL-3 KO mice had significantly
lower hematocrits than similarly infected WT mice of the same gender (Figure 7). Some
studies have suggested that IL-3 is involved in erythropoiesis (Change and Stevenson,
2004). Thus, the potential ability of IL-3 to act as an erythropoietic growth factor makes
suppression of erythropoiesis an especially pertinent factor in the development of anemia
in response to malaria infection. In order to determine the effect of IL-3 deficiency on
erythropoiesis, we determined the number of erythrocyte precursors in the bone marrow
and spleens of male WT and IL-3 KO mice at 8 days p.i. Prior to infection, there was no
significant difference in the number of blast-forming units erythroid (BFU-Es) or colonyforming units erythroid (CFU-Es) in either spleen or bone marrow (Figure 8, Table 2). At
day 8 p.i., BFU-Es were significantly elevated in KO, but not WT, spleens and bone
marrow. CFU-Es were significantly elevated in the spleen and bone marrow of both WT
and KO mice, but KO mice had significantly higher levels of CFU-Es in both bone
marrow and spleen compared to WT mice (Table 2).
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Figure 7. Hematocrit values in uninfected and P. berghei NK65-infected male and
female WT and IL-3 KO mice. Hematocrits of infected mice were determined on day 8
(male and female) and day 10 (female) p.i. Data from uninfected male and female mice
of each genotype were not significantly different and were pooled (D0). All data are
presented as means ± SD from 4 to 6 mice per group analyzed individually. ***, P <
0.001 versus corresponding values for uninfected mice or (as indicated by the square
brackets) versus corresponding values for mice of the other genotype. The data for male
(D8) and female (D10) mice are representative of three and two independent
experiments, respectively.
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Figure 8. Representative images of (A) a blast forming unit-erythroid colony at 100x
magnification, and (B) a colony forming unit-erythroid colony at 400x magnification.
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Table 2. Erythropoiesis in male WT and IL-3 KO mice during P. berghei NK65
infection.

No. of progenitor cellsa
Bone marrow
Mice

Spleen

BFU-E

CFU-E

BFU-E

CFU-E

WT

26.7 ± 1.5

27.0 ± 4.4

9.0 ± 2.0

7.7 ± 2.9

KO

23.3 ± 8.1

20.7 ± 4.0

7.0 ± 2.6

4.3 ± 3.1

21.7 ± 5.5

54.0 ± 8.7b

4.0 ± 1.0

236.0 ± 20.0c

Uninfected

Infected
WT
KO

48.0 ± 5.6be 150.7 ± 7.6ce 12.3 ± 4.2d 478.0 ± 41.4ce

a

Means ± SD from triplicate cultures for pooled cells obtained from male WT and IL-3
KO uninfected mice (n = 4/group) and WT and IL-3 KO mice (n = 6/group) infected for
8 days with P. berghei NK65. Statistical differences were measured using two-way
ANOVA with Bonferroni posttest. The data are representative of two independent
experiments.
b

Statistically significant difference compared to uninfected mice of the same genotype

(P < 0.01).
c

Statistically significant difference compared to uninfected mice of the same genotype

(P < 0.001).
d

Statistically significant difference compared to similarly infected WT mice
(P < 0.05).

e

Statistically significant difference compared to similarly infected WT mice
(P < 0.001).
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P. berghei NK65-infected IL-3 KO mice have higher levels of G-CSF, and lower
levels of IFN-γ and CLCX9, than WT counterparts
A number of cytokines are known to affect the course and outcome of
Plasmodium infection, with the host immune response depending upon the optimal
balance and timing of both inflammatory and anti-inflammatory cytokines. In order to
determine the effect of IL-3 deficiency on cytokine production in Plasmodium-infected
mice, a multiplex immunoassay was used to determine the levels of 32 lymphokines,
interferons, colony-stimulating factors, and chemokines present in the plasma of P.
berghei NK65-infected male WT and IL-3 KO mice at days 0, 4, and 8 p.i. Of the 32
analytes tested, 15 were increased in infected mice compared to uninfected (GM-CSF,
IL-1α, IL-1β, IL-6, IL-9, IL-10, IL-12 [p70], IL-13, IP-10, KC, MCP-1, M-CSF, MIP-1α,
MIP-1β, and TNF-α; data not shown), but only three showed significant differences in
expression between male WT and IL-3 KO mice: IFN-γ, CXCL9, and G-CSF.
Uninfected male WT and IL-3 KO mice produce nearly undetectable levels of
IFN-γ. At day 4 p.i., both male WT and KO mice had increased levels of IFN-γ, but WT
mice had significantly higher levels than IL-3 KO mice. By day 8 p.i., KO levels
increased to be approximately equal to those of WT mice (Figure 9A). The IFN-γinduced monokine CXCL9 followed a similar pattern, with male WT mice having higher
levels than KO mice at day 4 p.i. but no significant difference at day 8 p.i. (Figure 9B).
Prior to Plasmodium infection, here is no statistically significant difference
between male WT and IL-3 KO levels of G-CSF; by day 8 p.i. both WT and IL-3 KO
mice have significantly increased levels compared to uninfected, with IL-3 KO mice
having significantly higher levels than WT mice (Figure 9C). Since G-CSF supports the
proliferation and function of neutrophils, May-Grünwald-stained thin blood smears taken
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Figure 9. Levels of plasma IFN-γ (A), CXCL9 (B), and G-CSF (C) in uninfected and P.
berghei NK65-infected male WT and IL-3 KO mice. Infected animals were sacrificed on
days 4 and 8 p.i. Data are presented as means ± SD from 4 to 5 mice per group analyzed
individually. P < 0.05 (*), P < 0.01 (**), and P < 0.001 (***) versus corresponding
values for uninfected mice or (as indicated by the square brackets) versus corresponding
values for mice of the other genotype (two-way ANOVA with Bonferroni posttest). The
data are representative of two independent experiments.
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from uninfected and P. berghei NK65-infected male WT and KO mice were counted to
determine the % of neutrophils. There was no significant difference in the % of blood
neutrophils between uninfected WT and KO mice (Table 3). After infection with P.
berghei NK65, both WT and KO mice had increased % of blood neutrophils, but WT
mice had a significantly greater increase than KO mice.
WT mice produce IL-3 in response to infection with P. berghei NK65
Plasma levels of IL-3 were undetectable by multiplex assays in both uninfected
and infected WT mice, indicating that a local source of IL-3 is necessary in this model
system. To begin determining at what point during the infection significant levels of IL-3
begin to be produced, IL-3 secretion by antigen-stimulated splenocyte cultures was
examined using cells obtained from male WT mice at days 0, 2, 4, 6, and 8 p.i. (Figure
10). Levels of IL-3 were first detected in cultures containing splenocytes obtained at day
4 p.i. that were stimulated with P. berghei NK65 antigen but not control antigen or
medium alone. By day 6 p.i., even cultures containing control antigen and medium
contained IL-3, indicating extensive activation of cells in vivo.
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Table 3. Percentage of neutrophils present in the peripheral blood of uninfected and P.
berghei NK65-infected male WT and KO mice at 8 days p.i. (n = 5/group).

% neutrophils

Uninfected
Infected

WT

KO

34.0 ± 8.9

32.3 ± 4.4

62.5 ± 15.1a

42.1 ± 11.5a,b

a

Statistically significant difference compared to uninfected mice of the same genotype
(P < 0.05).
b

Statistically significant difference compared to similarly infected WT mice
(P < 0.05).
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Figure 10. IL-3 production by splenocytes isolated from P. berghei NK65-infected male
WT mice. Unfractionated spleen cells were isolated from mice at days 0, 2, 4, 6, and 8
p.i. (n = 4 mice/group). Pooled cells were cultured in triplicate for 48 h in the presence of
medium, control antigen, and parasite antigen, and supernatants were analyzed for IL-3
by ELISA. Data are presented as means ± SD from triplicate cultures.

Discussion

Although IL-3 is known to contribute to the host immune response to
gastrointestinal nematodes, little work has been done exploring the role of IL-3 in the
immune response to protozoan parasites such as Plasmodium. A recent genetic study
showed an association between certain single nucleotide polymorphisms in the gene
encoding IL-3 and protection against recurrent malaria attacks in humans; however, the
phenotypes associated with these polymorphisms are unknown, making it impossible to
determine whether IL-3 exerts a protective or detrimental effect (Meyer et al., 2011).
Earlier studies performed with the non-lethal rodent malaria P. chabaudi indicate that IL3 may play a role in initiating the switch from Th1 to Th2 immunity by stimulating IL-4
production by non-B non-T cells (Helmby et al., 1998), most likely of mast cell or
basophil origin (Poorafshar et al., 2000). Studies using the fatal strain P. berghei ANKA,
which recapitulates cerebral malaria in mice, showed that the co-administration of antiIL-3 and anti-GM-CSF antibodies prevented the development of cerebral malaria and
prolonged survival by preventing increased TNFα production by macrophages (Grau et
al., 1988). To date, the results reported here represent the only work that has been done
using IL-3 KO mice to explore the role of IL-3 in any model of rodent malaria.
Our results indicate that IL-3 plays a critical role in suppressing protective
immunity to P. berghei NK65 infection as monitored by survival and parasitemia.
Mortality caused by P. berghei NK65 differs significantly between males and females,
with WT males succumbing to infection 8 – 13 days p.i. while WT and IL-3 KO females
survive 3 – 4 weeks. Male IL-3 KO mice, however, have a survival curve more closely
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resembling that of female mice, with nearly half of KO mice surviving 3 weeks or longer
(Figure 3A-B). This suggests that IL-3 plays a detrimental role in the host response to P.
berghei NK65 infection in male, but not female mice. These data concur with similar
studies of P. chabaudi in IFN-γ receptor and IL-4 KO mice, in which male, but not
female, KO mice had shortened survival compared to their WT counterparts (Zhang et
al., 2000). Orchidectomy was found to abrogate the shortened survival in male both IL-4
and IFN-γ receptor KO mice, while ovariectomy had no effect on the course of infection
in females, suggesting that males and females respond to malaria infection via different
pathways, and that the male response is moderated by testosterone (Zhang et al., 2000).
These and other studies (Klein, 2004) strongly support that in both rodents and humans,
mortality rates are generally higher in males than in females and may relate to
immunological differences in the sexes. Due to the fact IL-3 deficiency prolonged
survival in males, but not females, many of the subsequent experiments were performed
in males only.
Differences in survival between male WT and IL-3 KO mice showed a strong
correlation with differences in parasitemia. Parasite levels in the blood were similar in
WT and IL-3 KO mice at days 4 and 6 p.i. However, at days 8 and 10 p.i., when male
WT mice begin to suffer significant mortality, parasitemia was greater in male WT mice
than in corresponding KO mice. The increased parasitemia observed in male WT mice
may not be the cause of death in these animals since male KO mice achieve higher
parasitemias before succumbing 3-4 weeks p.i. (data not shown). Differences in
parasitemia between male WT and IL-3 KO mice do not appear to reflect differences in
migration of parasites into the bloodstream, since both mouse strains cleared parasites
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from the peritoneal cavity by day 2 p.i. No significant difference in parasitemia was
observed between female WT and KO mice, which correlates with their similar survival
rates.
Malaria infection induces anemia in both humans and mice via a number of
mechanisms: the destruction of pRBCs by the developing parasites, clearance of pRBCs
by the host immune response, increased destruction of uninfected RBCs, and suppression
of erythropoiesis (Lamikanra et al., 2007). Our data shows that both male and female IL3 KO mice develop more severe anemia than WT mice in response to malaria infection
(Figure 6), and the reduced parasitemia in male IL-3 KO mice compared to WTs (Figure
3C) suggests that at least some of this increased anemia is due to more effective clearance
of pRBCs.
Given that IL-3 has been suggested to promote erythropoiesis under certain
conditions (Broughton et al., 2012), we also investigated the possibility that impaired
erythropoiesis is also a significant contributor to anemia in male IL-3 KO mice.
Surprisingly, male IL-3 KO mice actually produced higher numbers of erythroid
progenitors in both the bone marrow and the spleen than male WT mice in response to P.
berghei NK65 infection (Table 2), suggesting that IL-3 may suppress erythropoiesis.
Suppression of erythropoiesis has been reported for other cytokines, including IFN-γ,
TNF-α, and IL-10 (Lamikanra et al., 2007), suggesting that the elevated levels of IFN-γ
in male WT mice (Figure 8A) may also be suppressing erythropoiesis in these animals.
Previous studies have found lower levels of BFU-Es and CFU-Es in lethal malaria
infections compared to non-lethal infections (Villeval et al., 1990; Weiss, 1989), which
agrees with our finding that the longer-surviving male KO mice have increased
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erythropoiesis compared to male WT mice and suggests that a robust splenic
erythropoietic response supports survival in malaria-infected mice.
The increased erythropoiesis seen in male IL-3 KO mice may also be a direct
result of the KO mice’s greater anemia and resulting increased demand for RBCs. Mice
infected with P. chabaudi have been shown to produce erythropoietin (EPO) in response
to malaria-induced anemia (Nairz et al., 2012). EPO upregulates erythropoiesis in
response to RBC destruction and the resulting reduction in blood oxygen tension (Nairz
et al., 2012). EPO has also been shown to play an anti-inflammatory role in malaria
infection, and administration of exogenous EPO to P. berghei NK65-infected mice
prolongs survival (Nairz et al., 2012). It remains to be determined whether P. berghei
NK65-infected IL-3 KO mice produce higher levels of EPO than WT mice to correspond
to their greater anemia; if so, this could be one factor contributing to their prolonged
survival.
The spleen plays several important roles in the host immune response to malaria
infection, removing damaged and pRBCs from circulation, as a site for erythropoiesis and
hematopoiesis, and as a secondary lymphoid organ where T cell and B cell responses can
occur (Engwerda et al., 2005). Our results showing increased splenomegaly in the longersurviving IL-3 KO mice agree with the literature suggesting that the degree of
splenomegaly correlates with the effectiveness of the immune response (Cadman et al.,
2008). Mast cells (Furuta et al., 2006) and basophils (Poorafshar et al., 2000) have both
been shown to increase in the spleens of Plasmodium-infected mice, and mast cell
derived TNF-α (Furuta et al., 2006) and Flt3 ligand (Guermonprez et al., 2013) have
been shown to play important roles in the immunopathology of mice infected with P.
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berghei NK65. In spite of the importance of mast cells in the host response to malaria
infection, as well as the known ability of IL-3 to influence mast cell function, no
difference in the number of mast cells per mm2 of spleen tissue was detected between
male WT and KO mice either before or 8 days after infection with P. berghei NK65
(Table 1). Both genotypes, however, showed a marked decrease in splenic mast cells
postinfection, which may be due either to mast cell activation (degranulated mast cells
cannot be detected using pinacyanol erythrosinate staining), or to the over-all increase in
spleen size. Although IL-3 is also known to influence the proliferation and function of
basophils, preliminary experiments have shown no difference in the number of splenic or
blood basophils in P. berghei NK65-infected male WT and KO mice.
The spleen is made up of red pulp, a network of reticular cells and macrophages
which perform the filtration functions of the spleen, and white pulp, where pathogenspecific B cell and T cell responses are generated (Engwarda et al., 2005). The white pulp
is separated from the red pulp by the marginal zone (Engwarda et al., 2005).
Hematoxylin-eosin (H&E) staining was performed on spleen sections in order to compare
the relative areas of red and white pulp between uninfected and P. berghei NK65-infected
male WT and KO mice (Figure 10). Spleens of uninfected WT and KO mice were
similar, with well-defined areas of white pulp surrounded by a visible marginal zone
separating them from the red pulp. After infection, however, the spleens of both WT and
KO mice showed a dramatic loss of definition between the red and white pulp and
shrinkage of the marginal zone, which agrees with previous studies on histological
changes in the spleen caused by malaria infection (Cadman et al., 2008; Engwerda et al.,
2005). Although more definitive studies of differences in splenic architecture need to be
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completed, these data suggest that increased expansion of the splenic erythroid
compartment in P. berghei NK65-infected KO mice in part accounts for the increased
splenomegaly seen in KO mice.
Cytokines play a wide variety of roles in immunity to infection, recruiting and
signaling between various effector cells as well as endothelial cells (Wiser, 2011). Since
the complexity of the immune response to malaria infection and dearth of literature on the
role played by IL-3 makes it difficult to predict which cytokines will be affected by the
absence of IL-3, a multiplex assay was used to compare the levels of 32 major cytokines
in plasma collected from P. berghei NK65-infected male IL-3 KO and WT mice at days
0, 4, and 8 p.i. Of these cytokines, 3 were found to be significantly different between P.
berghei NK65-infected IL-3 KO and WT mice: IFN-γ, CXCL9, and G-CSF (Figure 8).
These results do not definitively eliminate the remaining 29 cytokines as possible factors
in the difference between the IL-3 KO and WT responses to P. berghei NK65 infection;
many cytokines act locally rather than systemically and may not be present at detectible
levels in plasma.
IFN-γ is an inflammatory cytokine produced primarily by lymphocytes including
αβ T cells, natural killer (NK) cells, NKT cells, and γδ T cells (Inoue et al., 2013). There
have also been reports of IFN-γ production by myeloid cells (Inoue et al., 2013),
including mast cells (Marone et al., 2000). IFN-γ production is the defining characteristic
of Th1 cells, making it a critical factor in the balance between Th1 and Th2 immunity
(Angulo and Fresno 2002.) The importance of INF-γ as a protective factor in the immune
response to malaria infection has been well established (Angulo and Fresno, 2002).
Therefore, we were surprised to find that the male WT mice had higher levels of IFN-γ at
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day 4 p.i. with P. berghei NK65 than the longer-surviving male IL-3 KO mice (Figure
8A). This could reflect the fact that effect of IFN-γ can exert a protective or pathological
effect depending on the strain of parasite and mouse. Although IFN-γ has been shown to
be essential for immunity to P. chabaudi infection (Angulo and Fresno, 2002; Su and
Stevenson 2002), IFN-γ has been implicated in the development of cerebral malaria in P.
berghei ANKA-infected C57BL/6 mice (Su and Stevenson, 2002; Angulo and Fresno,
2002). The role of IFN-γ in the immune response to P. berghei NK65 infection is less
clear: there is no significant difference in survival between BALB/c WT and IFN-γ KO
mice infected with P. berghei NK65 (Ishih et al., 2008), however, treatment with antiIFN-γ antibodies significantly prolongs survival in C57BL/6 mice infected with P.
berghei NK65 (Yoshimoto et al., 1998). Therefore, it seems plausible that IFN-γ could
contribute to immunopathology related to its inflammatory functions in this disease
model. IFN-γ also promotes antibody class switching to the IgG2 isotype in mice;
however, we found no difference in IgG2 antibody levels between P. berghei NK65infected male WT and IL-3 KO mice (data not shown).
CXCL9, also known as monokine induced by IFN-γ (MIG), is a T cell
chemoattractant produced by macrophages and other cells in response to IFN-γ (Liao et
al., 1995). Since CXCL9 is induced by IFN-γ production, it is unsurprising that CXCL9
expression in the plasma of P. berghei NK65-infected male WT and IL-3 KO mice is
similar to that of IFN-γ, with WT mice expressing higher levels than KO mice at day 4
p.i. and WT and KO mice expressing similar levels at day 8 p.i. (Figure 8B). Like IFN-γ,
CXCL9 has been shown to be essential to the development of cerebral malaria
(Campanella et al., 2008). CXCL9 was also found to be upregulated in the cerebral
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microvasculature of BALB/c mice infected with P. berghei NK65 (Lacerda-Queiroz et
al., 2011). Although P. berghei NK65 infection does not cause the neurological
symptoms of classical cerebral malaria (ataxia, paralysis, convulsions, and coma
followed by death), P. berghei NK65-infected BALB/c mice did show increased cerebral
vascular permeability and levels of leukocyte rolling and adhesion comparable to that
seen in P. berghei ANKA infection (Lacerda-Queiroz et al., 2011). This suggests that
CXCL9, like IFN-γ, could contribute to WT mortality via inflammation-related
immunopathology.
G-CSF is a growth factor that supports the proliferation, survival, and
differentiation of neutrophils (Touw and van de Geijn, 2007). G-CSF also induces
mobilization of neutrophils from the bone marrow and enhances neutrophil function
(Touw and van de Geijn, 2007). Neutrophils are the most abundant leukocyte in the
circulation and typically form the first line of defense against infection, phagocytizing
pathogens and then undergoing apoptosis to be themselves consumed by macrophages
(Mόcsai, 2013). In addition, neutrophils are thought to help regulate the immune response
by releasing inflammatory mediators as well as participating in the regulation of B and T
cells, dendritic cells, and NK cells (Mόcsai, 2013). Although classically considered
essential for defense against extracellular pathogens such as bacteria and fungi, there is
recent evidence suggesting that neutrophils may also play a role in the host defense
against intracellular pathogens (Mόcsai, 2013). In a mouse model of experimental
cerebral malaria, P. berghei ANKA-infected mice developed a population of neutrophils
expressing the high-affinity IgE antibody receptor FcεRI, which is normally expressed by
mast cells and basophils (Porcherie et al., 2011.) These FcεRI+ neutrophils, which
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migrated to the brain, were shown to be required for the development of cerebral malaria
in infected mice, possibly by producing IFN-γ (Porcherie et al., 2011).
Our own preliminary results showed an increase in the % blood neutrophils in P.
berghei NK65-infected male WT and IL-3 KO mice, with a significantly higher
percentage of neutrophils in WT mice at day 8 p.i. (Table 3.) Since white blood cell
counts were not taken, it cannot be certain that the higher % neutrophils represent higher
absolute numbers of neutrophils in the blood of infected male WT mice. Assuming that
the lower % neutrophil counts in male IL-3 KO represent lower absolute numbers of
neutrophils, the higher G-CSF production seem in male IL-3 KO mice could well
represent a compensatory mechanism to increase neutrophil levels. Decreased neutrophil
counts in male IL-3 KO mice could be due to impaired production of neutrophils in IL-3
KO mice, or increased loss of neutrophils due to phagocytosis and apoptosis. The latter
possibility is intriguing since it could help to account for the enhanced parasite clearance
seen in male IL-3 KO mice, although macrophages are generally considered the primary
phagocytes responsible for clearance of Plasmodium parasites and pRBCs from the
bloodstream (Angulo and Fresno, 2002).
It is important to note that IL-3 levels in blood or tissues are low or undetectable
in normal mice using most assays (Neel et al., 2004). This was supported by our findings
that IL-3 was barely detectable in the plasma of P. berghei NK65-infected male WT mice
(data not shown), indicating that IL-3 is produced and used locally rather than
systemically in this model system. Our IL-3 kinetic study using spleen culture
supernatants indicates that IL-3 production begins as early as day 4 p.i. (Figure 9);
however, the fact that there are already detectable differences in the cytokine levels
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expressed by P. berghei NK65-infected WT and KO mice at this time point suggests that
IL-3 production begins even earlier. More sensitive assays will be needed to pinpoint the
timing of IL-3 production as well as identify its cellular source.
The results of this study, which were recently published in the journal Infection
and Immunity (Auclair et al., 2014), have established the novel finding that endogenous
IL-3 significantly contributes to the susceptibility of male BALB/c mice to blood-stage
infection with the lethal rodent malaria P. berghei NK65. This is supported by the
findings that P. berghei NK65-infected male IL-3 KO mice have prolonged survival,
decreased parasitemia, increased erythropoiesis, and increased splenomegaly compared to
their WT counterparts. Although P. berghei NK65-infected IL-3 KO mice also
experience more severe anemia than WT mice, this appears to be due to enhanced
clearance of pRBCs and so is consistent with a detrimental role for IL-3 in the host
response to malaria infection. Intriguingly, the influence of IL-3 on malaria infection
does not appear to be mediated through mast cells or basophils, the primary mature
effector cells that respond to IL-3. However, while we found no difference between P.
berghei NK65-infected male WT and IL-3 KO mice in blood basophil or splenic mast
cell numbers, our results cannot rule out the possibility that IL-3 is influencing the
functions of these cells. More work is needed to elucidate the mechanism(s) by which
IL-3 exerts its effects; however, several lines of evidence suggest that IL-3 contributes to
a potentially damaging inflammatory immune response to Plasmodium infection. These
include: suppressed erythropoiesis in P. berghei NK65-infected male WT mice compared
to IL-3 KOs, higher levels of the inflammatory cytokines IFN-γ and CXCL9, and,
pending confirmation of our preliminary results, higher % neutrophil counts. Taken
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together, these observations not only suggest new avenues of research into the effect of
IL-3 on malaria infection but into the role of IL-3 in the host response to disease. Some
particularly promising areas for further study include repeating the male-only
experiments (spleen histology, erythropoiesis, cytokines, and IL-3 kinetics) in female
mice as well as determining the effect of IL-3 deficiency on the host response to different
rodent Plasmodium species such as the non-lethal parasite P. chabaudi. Given that
basophil and mast cells are such important mediators of the effects of IL-3, more work
should be done exploring the activation and function of these cells in Plasmodiuminfected WT and IL-3 KO mice. Finally, given the higher IFN-γ levels seen in P. berghei
NK65-infected male WT mice compared to IL-3 KO mice, as well as the well-established
importance of this cytokine during malaria infection, experiments could be performed to
determine if anti-IFN-γ treatment could improve the WT response to P.berghei NK65
infection, or, conversely, if the administration of exogenous IFN-γ could decrease
survival time in P. berghei NK65-infected IL-3 KO mice.
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